Global Coalition on Aging Calls on Policy-Makers to Address Cardiovascular Disease to Promote Healthy Aging

(New York – 1 April 2019) – Today, the Global Coalition on Aging (GCOA), in collaboration with Bayer, released a new report titled Healthy Heart for Healthy Aging: The Need for Awareness, Innovation, and Collaboration in Cardiovascular Health, which examines the cardiovascular health imperative aligned with population aging.

The report highlights the current momentum from the global health community that makes now the opportune time to advance a healthy aging agenda for cardiovascular diseases. The report calls for specific policy actions that will advance ongoing innovation and engage a wide range of stakeholders.

“As the prevalence of cardiovascular diseases rise with the aging of the population – already 1 billion of us over 60 globally and growing to 2 billion by mid-century – now is the time for action,” said Michael W. Hodin, PhD, CEO of GCOA. “We’ve seen incredible innovations in cardiovascular health over the past 50 years, yet CVDs remain the number one cause of death globally.  Unfortunately, this trend will continue with increasing longevity unless policy-makers and public health leaders commit to alleviating the impacts on patients, health systems, economies and society.”

With over 17 million deaths worldwide, CVDs are the largest noncommunicable disease (NCD) by morbidity and mortality. From 1990 to 2016, the number of global, annual CVD deaths increased by more than 40% – from around 12 million to over 17 million – increasing CVDs’ share of total mortality from 27% to 32% of all deaths. CVDs impose an immense burden on individuals and health systems, due to the costs of the diseases and their comorbidities. Yet too often, these diseases are misunderstood as a natural condition of becoming old when in fact proactive attention to prevention, treatments, and care can change the incidence and prevalence of these conditions regardless of age.

“Over the past decades, innovative treatments have contributed to an increase of the average life span. As we continue to see rapidly aging populations around the world, effectively tackling and managing age-related illnesses have become pivotal,” said Dr. Michael Devoy, Chief Medical Officer of Bayer AG. “We have to focus on addressing these unmet needs, by embracing the opportunities around scientific progress and innovation in order to establish a sustainable framework for the future.”

The report calls for action in three areas:

  • Awareness: Meaningful policy action on CVDs must promote awareness and education amongst the public, patients, caregivers, and healthcare professionals to empower healthy choices that reduce risk for CVDs and related health challenges.
  • Innovation: Policy-makers must recognize that innovation moves primarily through incremental advances, so we must accept a research paradigm aligned with this stepwise progression.
  • Collaboration: Effectively addressing the direct and indirect impacts of CVDs will require policies and platforms that engage a wide range of actors, including government agencies, health systems, the private sector, non-profits, multilateral organizations, and advocacy groups.

In recent years, leading global, multilateral, and national institutions and health policy decision-makers – including the WHO, OECD, G20, governments, and others – have recognized the need to address the growing health and economic challenges related to population aging. Landmark public policy initiatives, like WHO’s Decade of Healthy Ageing and the G20 Principles on Silver Economy and Active Aging, have generated global momentum for successful aging. Now, policy-makers must continue this momentum to establish frameworks, programs, and collaborations that realize a sustainable course for healthy and active aging, and CVDs require urgent attention.

“The rise in cardiovascular disease should serve as a major call to action for policy-makers, the health sector, patient advocates, and the public,” said Dr. Holly S. Andersen, MD, Director of Education and Outreach, Ronald O. Perelman Heart Institute. “Innovations in healthcare, medicine, and technology have brought us longer lives, but the next era of innovation is needed as a driver of longer – and healthier – lives.”

To read the full report, click here.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.

Our National Conversation on Aging

Now that President Biden officially declared his run for a second term, what are we to make of the countless warnings about his age? Clearly, voters have already considered age a major factor – Google Search results for ‘Biden age’ hit an all-time-high just before the 2020 election – and speculation has only heightened four years on. Unfortunately, these concerns are misguided and even dangerous because they conflate age with poor health and confuse ideas about work and retirement.

World Immunization Week: Best-Kept Secret for 21st-Century Healthy Aging

The tremendous success of childhood immunisation campaigns across the 20thcentury is one of the greatest triumphs of public health. Along with advances in sanitation and antibiotics, childhood immunisation has resulted in the miracle of modern longevity: the once extravagant prospect of growing old has become the norm. Now, in our 21st century, isn’t it our great challenge to build on this achievement by realising a healthy longevity?

South China Morning Post Letter to the Editor

Antimicrobial resistance is one of the defining global problems of our time. Drug-resistant bacterial infections killed an estimated 1.27 million people in 2019. By 2050, 10 million lives annually could be lost to antimicrobial resistance, and annual global gross domestic product could fall by between 1.1 per cent and 3.8 per cent. Fortunately, Chinese policymakers, physicians and patients have shown what is possible when they focus collective efforts on antimicrobial resistance.

Medicine Price Setting Might Appeal to Voters but Will Cost Patients

As policymakers search for potential cuts to the national budget, they risk jeopardizing the country’s most cost-effective use of healthcare dollars: biomedical innovation regarding vaccines , prescription drugs, and emerging therapies, including antibodies. As the nation rapidly ages, protecting this pipeline of medicine will not only improve health outcomes but will do so at a lower cost by reducing more expensive hospital and primary care.

Global Coalition on Aging Hosts Cross-Sector Roundtable to Tackle Heart Valve Disease in Aging Societies

The Global Coalition on Aging (GCOA) and the Global Heart Hub have released a global position paper “Heart Valve Disease: Harnessing Innovation to Save Lives, Mitigate Costs, and Advance the Healthy Aging Agenda.” The report builds upon on a December 2022 GCOA-GHH roundtable of cross-sector experts and examines how behavior and policy change can best address heart valve disease in our 21st century.

New York City Twins with Ireland to Develop Age Friendly Communities

The twinning commits both sides to share knowledge on age friendly programs and builds on the 2011 Dublin Declaration of Age-Friendly Cities and Communities. The agreement was signed by the Cathaoirleach (Mayor) Nick Killian of Meath County Council which hosts the Irish Age Friendly Programme and Lorraine Cortés-Vázquez, Commissioner for Aging.

Just Getting Started at 75

In the latest charge against the promise of healthy aging, Dr. Ezekiel Emanuel, oncologist and bioethicist, doubled down on his infamous 2014 essay stating that 75 is the ideal age to die. Now 65, he maintains that after age 75, he will no longer receive medical screenings and interventions like colonoscopies, cancer treatment, flu shots, and heart valve replacement.